Chatterjee Prabal K, Zacharowski Kai, Cuzzocrea Salvatore, Brown Paul A J, Stewart Keith N, Mota-Filipe Helder, Thiemermann Christoph
Department of Experimental Medicine & Nephrology, William Harvey Research Institute, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, England, United Kingdom.
Kidney Int. 2002 Oct;62(4):1249-63. doi: 10.1111/j.1523-1755.2002.kid580.x.
BACKGROUND: The aim of this study was to investigate whether in vivo administration of a low, sub-lethal dose of lipoteichoic acid (LTA), a bacterial wall-fragment derived from the Gram-positive bacterium Staphylococcus aureus, protects the kidney against the renal dysfunction and injury caused by ischemia/reperfusion (I/R). METHODS: Male Wistar rats were administered LTA from S. aureus (1 mg/kg, IP). After 24 hours, rats were subjected to bilateral renal ischemia (45 min) followed by reperfusion (6 h). Serum and urinary markers were measured for the assessment of renal function, tubular and reperfusion-injury. Renal sections were used for histological grading of renal injury and for immunohistochemical localization of P-selectin, inducible nitric oxide synthase (iNOS) and nitrotyrosine (indicative of peroxynitrite formation). Kidney myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured for assessment of polymorphonuclear (PMN) cell infiltration and lipid peroxidation, respectively. Nitric oxide (NO) production was determined by measurement of plasma nitrite/nitrate levels. RESULTS: LTA pretreatment significantly reduced renal dysfunction, tubular and reperfusion-injury caused by I/R of the kidney as well as histological evidence of renal injury. LTA also reduced the expression of P-selectin and kidney MPO activity associated with renal I/R. MDA levels were significantly reduced by LTA pretreatment suggesting a reduction in the lipid peroxidation and formation of reactive oxygen species (ROS). LTA pretreatment also markedly reduced both the expression of iNOS and the formation of nitrotyrosine associated with renal I/R. Although LTA significantly reduced plasma nitrite/nitrate levels associated with I/R, nitrite/nitrate levels remained at levels significantly higher than that measured from the plasma obtained from Sham-operated animals. CONCLUSIONS: These data suggest, to our knowledge for the first time, that LTA pretreatment for 24 hours significantly reduces renal I/R injury. We propose that the mechanism of the protective effect involves reduction of the production of NO, ROS and peroxynitrite subsequent to reduced P-selectin and iNOS expression and PMN recruitment. However, although LTA pretreatment resulted in a reduction of iNOS expression and NO production, we hypothesize that the remaining significant levels of NO contribute to the beneficial actions provided by LTA.
背景:本研究的目的是调查体内给予低剂量、亚致死剂量的脂磷壁酸(LTA)(一种源自革兰氏阳性菌金黄色葡萄球菌的细菌细胞壁片段)是否能保护肾脏免受缺血/再灌注(I/R)引起的肾功能障碍和损伤。 方法:对雄性Wistar大鼠腹腔注射金黄色葡萄球菌的LTA(1mg/kg)。24小时后,对大鼠进行双侧肾脏缺血(45分钟),随后再灌注(6小时)。测量血清和尿液标志物以评估肾功能、肾小管和再灌注损伤。肾组织切片用于肾损伤的组织学分级以及P-选择素、诱导型一氧化氮合酶(iNOS)和硝基酪氨酸(指示过氧亚硝酸盐形成)的免疫组织化学定位。分别测量肾脏髓过氧化物酶(MPO)活性和丙二醛(MDA)水平以评估多形核(PMN)细胞浸润和脂质过氧化。通过测量血浆亚硝酸盐/硝酸盐水平来测定一氧化氮(NO)的产生。 结果:LTA预处理显著降低了肾脏I/R引起的肾功能障碍、肾小管和再灌注损伤以及肾损伤的组织学证据。LTA还降低了与肾脏I/R相关的P-选择素表达和肾脏MPO活性。LTA预处理使MDA水平显著降低,表明脂质过氧化和活性氧(ROS)形成减少。LTA预处理还显著降低了与肾脏I/R相关的iNOS表达和硝基酪氨酸的形成。尽管LTA显著降低了与I/R相关的血浆亚硝酸盐/硝酸盐水平,但亚硝酸盐/硝酸盐水平仍显著高于假手术动物血浆中的测量水平。 结论:据我们所知,这些数据首次表明LTA预处理24小时可显著降低肾脏I/R损伤。我们提出,保护作用的机制涉及在P-选择素和iNOS表达以及PMN募集减少后,减少NO、ROS和过氧亚硝酸盐的产生。然而,尽管LTA预处理导致iNOS表达和NO产生减少,但我们推测剩余的显著水平的NO有助于LTA提供的有益作用。
Free Radic Biol Med. 2010-6-30
Toxicol Rep. 2019-12-30
Curr Pharm Des. 2014
Biomed Res Int. 2013
J Neuroinflammation. 2012-7-6
Neurocrit Care. 2009-8-28
Naunyn Schmiedebergs Arch Pharmacol. 2007-10